0.6522
-0.0248 (-3.66%)
-0.0248 (-3.66%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 621,457 |
|
|||||
| News | - | ||||||
| Day High | 0.68 | Low High |
|||||
| Day Low | 0.62 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| AcelRX Pharmaceuticals Inc | ACRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.0248 | -3.66% | 0.6522 | 00:00:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.677 | 0.62 | 0.68 | 0.6522 | 0.677 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,591 | 621,457 | $ 0.6555532 | $ 407,398 | - | 0.62 - 2.94 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:58:35 | formt | 287 | $ 0.65 | USD |
Period:
Draw Mode:
AcelRX Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 77.82M | 119.32M | 117.84M | $ 5.42M | $ - | -0.47 | -2.10 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 2.50% |
AcelRX Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.685 | 0.749 | 0.62 | 0.6941716 | 1,071,903 | -0.0328 | -4.79% |
| 1 Month | 0.885 | 0.92 | 0.62 | 0.7677022 | 1,092,932 | -0.2328 | -26.31% |
| 3 Months | 1.10 | 1.10 | 0.62 | 0.8990623 | 830,481 | -0.4478 | -40.71% |
| 6 Months | 1.25 | 1.67 | 0.62 | 1.22 | 1,471,605 | -0.5978 | -47.82% |
| 1 Year | 1.57 | 2.94 | 0.62 | 1.75 | 2,663,301 | -0.9178 | -58.46% |
| 3 Years | 3.72 | 4.09 | 0.62 | 2.00 | 1,780,994 | -3.07 | -82.47% |
| 5 Years | 3.05 | 5.75 | 0.62 | 2.39 | 1,524,817 | -2.40 | -78.62% |
AcelRX Pharmaceuticals Description
| AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-02 and ARX-03. The majority of its revenue is generated from DSUVIA product sales in the United States. |
